Theseus Pharmaceuticals, Inc.
THRX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $117,828 | $408,059 | $376,256 | $192,745 |
| - Cash | $46,893 | $47,465 | $109,698 | $94,605 |
| + Debt | $3,656 | $3,768 | $3,877 | $3,979 |
| Enterprise Value | $74,591 | $364,362 | $270,435 | $102,119 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$23 | -$159 | -$155 | -$152 |
| % Margin | – | – | – | – |
| EBITDA | -$16,381 | -$17,566 | -$17,035 | -$11,981 |
| % Margin | – | – | – | – |
| Net Income | -$13,504 | -$14,805 | -$12,117 | -$15,433 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.31 | -0.34 | -0.29 | -0.4 |
| % Growth | 8.8% | -17.2% | 27.5% | – |
| Operating Cash Flow | -$11,026 | -$10,039 | -$18,630 | -$9,937 |
| Capital Expenditures | -$50 | -$11 | $11 | -$11 |
| Free Cash Flow | -$11,076 | -$10,050 | -$18,619 | -$9,948 |